- Home
- WST vs MTZ Comparison
WST vs MTZ Comparison
Compare WST & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WST | MTZ |
|---|---|---|
| Founded | 1923 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 24.9B |
| IPO Year | 2004 | 2005 |
Fundamental Metrics
Financial Performance| Metric | WST | MTZ |
|---|---|---|
| Price | $331.30 | $335.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 18 |
| Target Price | $325.86 | ★ $339.47 |
| AVG Volume (30 Days) | 726.5K | ★ 1.1M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.30% | N/A |
| EPS Growth | 1.49 | ★ 146.12 |
| EPS | ★ 4.07 | 0.77 |
| Revenue | $2,886,900,000.00 | ★ $14,299,171,000.00 |
| Revenue This Year | $6.76 | $20.38 |
| Revenue Next Year | $6.22 | $10.18 |
| P/E Ratio | ★ $81.39 | $437.39 |
| Revenue Growth | 1.95 | ★ 16.22 |
| 52 Week Low | $223.83 | $160.08 |
| 52 Week High | $386.00 | $441.43 |
Technical Indicators
Market Signals| Indicator | WST | MTZ |
|---|---|---|
| Relative Strength Index (RSI) | 38.40 | 38.24 |
| Support Level | $321.94 | $326.93 |
| Resistance Level | $336.82 | $435.67 |
| Average True Range (ATR) | 11.14 | 17.24 |
| MACD | -4.53 | -2.91 |
| Stochastic Oscillator | 8.30 | 9.68 |
Price Performance
Historical ComparisonAbout WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.